Comparative analysis of global practices in the management of colchicine-resistant familial Mediterranean fever: a CliPS network analysis

Background Although colchicine is the mainstay of familial Mediterranean fever (FMF) treatment, 5–10% of patients are considered to have colchicine resistance (CR). However, there is no globally agreed CR definition or indications for biological disease-modifying anti-rheumatic drugs (bDMARDs).Metho...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Michael Hofer, Veronique Hentgen, Anna Mamutova, Tamàs Constantin, Mario Sestan, Rim Bourguiba, Marion Delplanque, Helmut Wittkowski, Helen Lachmann, Jürgen Brunner, Roberta Caorsi, Muserref Kasap Cuceoglu, Konstantinos Pateras, Betul Sozeri, Inès Elhani, Stefan Backes, Fatih Haslak, Nimet Oner, Tanja Hinze, Yonatan Butbul Aviel, Stéphanie Ducharme Bénard, Majdouline El Moussaoui, Meri Kirijas, Sonia Carriquí Arenas, Ghalia Khellaf, Vafa Guliyeva, Naiera Assalia, Nuray Ayaz
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	BMJ Publishing Group 2025-09-01
سلاسل:	RMD Open
الوصول للمادة أونلاين:	https://rmdopen.bmj.com/content/11/3/e006097.full
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!